Articles with public access mandates - Katarzyna Tomczak, PhDLearn more
Available somewhere: 18
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
K Tomczak, P Czerwińska, M Wiznerowicz
Contemporary Oncology/Współczesna Onkologia 2015 (1), 68-77, 2015
Mandates: US National Institutes of Health
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ...
Nature communications 12 (1), 6071, 2021
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
TRIM28 and interacting KRAB-ZNFs control self-renewal of human pluripotent stem cells through epigenetic repression of pro-differentiation genes
U Oleksiewicz, M Gładych, AT Raman, H Heyn, E Mereu, ...
Stem cell reports 9 (6), 2065-2080, 2017
Mandates: US National Institutes of Health, Government of Spain
TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development
P Czerwińska, PK Shah, K Tomczak, M Klimczak, S Mazurek, B Sozańska, ...
Oncotarget 8 (1), 863, 2016
Mandates: US National Institutes of Health
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
N Baran, A Lodi, Y Dhungana, S Herbrich, M Collins, S Sweeney, ...
Nature communications 13 (1), 2801, 2022
Mandates: US National Institutes of Health, Canadian Cancer Society, Canadian …
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer
E Orouji, AT Raman, AK Singh, A Sorokin, E Arslan, AK Ghosh, J Schulz, ...
Gut 71 (5), 938-949, 2022
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy
CJ Terranova, M Tang, M Maitituoheti, AT Raman, AK Ghosh, J Schulz, ...
Cell reports 36 (3), 2021
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
Dysregulation and epigenetic reprogramming of NRF2 signaling axis promote acquisition of cisplatin resistance and metastasis in head and neck squamous cell carcinoma
AA Osman, E Arslan, M Bartels, C Michikawa, A Lindemann, K Tomczak, ...
Clinical Cancer Research 29 (7), 1344-1359, 2023
Mandates: US National Institutes of Health
Next-generation immunotherapies to improve anticancer immunity
Y Shi, K Tomczak, J Li, JK Ochieng, Y Lee, C Haymaker
Frontiers in pharmacology 11, 566401, 2021
Mandates: US National Institutes of Health
Immune landscape of a genetically engineered murine model of glioma compared with human glioma
DB Zamler, T Shingu, LM Kahn, K Huntoon, C Kassab, M Ott, K Tomczak, ...
JCI insight 7 (12), 2022
Mandates: US National Institutes of Health
Genomic correlates of outcome in tumor-infiltrating lymphocyte therapy for metastatic Melanoma
CA Creasy, YJ Meng, MA Forget, T Karpinets, K Tomczak, C Stewart, ...
Clinical Cancer Research 28 (9), 1911-1924, 2022
Mandates: US National Institutes of Health, Melanoma Research Alliance
Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance
H Fan, F Wang, A Zeng, A Murison, K Tomczak, D Hao, FZ Jelloul, ...
Communications Biology 6 (1), 765, 2023
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
Bivalent and broad chromatin domains regulate pro-metastatic drivers in melanoma
C Terranova, M Tang, M Maitituoheti, AT Raman, J Schulz, SB Amin, ...
bioRxiv, 721480, 2019
Mandates: US National Institutes of Health
Single-cell characterization of acute myeloid leukemia and its microenvironment following PD-1 blockade based therapy
HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ...
Biorxiv, 2020.09. 03.278309, 2020
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
New cellular models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor
AD Bhalla, SM Landers, AK Singh, MG Yeagley, GSB Meyerson, ...
bioRxiv, 2021.05. 13.443902, 2021
Mandates: US National Institutes of Health
Immune landscape of a genetically-engineered murine model of glioma relative to human glioma by single-cell sequencing v2
DB Zamler, T Shingu, LM Kahn, C Kassab, M Ott, K Tomczak, J Liu, Y Li, ...
bioRxiv, 2021
Mandates: US National Institutes of Health
Overcoming NOTCH1-driven chemoresistance in T-cell acute lymphoblastic leukemia via metabolic intervention with oxphos inhibitor
N Baran, A Lodi, Y Dhungana, SR Sweeney, P Renu, S Herbrich, FW Hoff, ...
Blood 136, 18-20, 2020
Mandates: US National Institutes of Health, German Research Foundation, Cancer …
Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations
N Deboever, N Zhou, DJ McGrail, K Tomczak, JL Oliva, HA Feldman, ...
Frontiers in Oncology 13, 1216999, 2023
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program